Phase I Study of BI 853520, an Inhibitor of Focal Adhesion...

  • Main
  • 2019 / 2
  • Phase I Study of BI 853520, an Inhibitor of Focal Adhesion...
Targeted Oncology 2019 / 2

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

de Jonge, Maja J. A., Steeghs, Neeltje, Lolkema, Martijn P., Hotte, Sebastien J., Hirte, Hal W., van der Biessen, Diane A. J., Abdul Razak, Albiruni R., De Vos, Filip Y. F. L., Verheijen, Remy B., Sch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Targeted Oncology
DOI:
10.1007/s11523-018-00617-1
Date:
February, 2019
File:
PDF, 719 KB
2019
Conversion to is in progress
Conversion to is failed